TABLE 2.
Study type | Findings | Ref. |
---|---|---|
Experimental study | NEP inhibitors increase GLP‐1 level. | Hupe‐Sodmann et al 54 |
Experimental study | NEP inhibitors insulin sensitivity by increasing of GLP‐1 and decrease DPP4 activity. | Willard et al 36 |
Experimental study | Dual inhibition of DPP4 and NEP increases the half‐life of GLP‐1. | Plamboeck et al 40 |
A randomized, controlled study | Augmentation of GIP by NEP inhibitors improves glucose homeostasis and insulin sensitivity in T2DM patients. | Frias et al 56 |
Review | NEP inhibitors improve glucose homeostasis and insulin sensitivity by increasing level of NPs. | Moro et al 60 |
Review | NEP inhibitors improve insulin sensitivity and glucose homeostasis by increasing bradykinin level. | Campbell 64 |
Review | LCZ696 can enhance insulin sensitivity and glucose homeostasis by increasing oxytocin serum level. | Dargad et al 68 |
Abbreviations: DPP4, dipeptidyl peptidase‐4; GIP, glucose‐dependent insulinotropic peptide; GLP‐1, glucagon‐like peptide 1; NEP, neprilysin; NP, natriuretic peptide; T2DM, type 2 diabetes mellitus.